Kay Hagan Tick Reauthorization Act
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Overview
The Kay Hagan Tick Reauthorization Act aims to extend and update the provisions of the Kay Hagan Tick Act, which supports efforts to combat tick-borne diseases. Specifically, it modifies the National Strategy for Vector-Borne Diseases and provides continued funding for regional centers of excellence. The bill adjusts the funding period for these programs to cover the years 2026 through 2030. It seeks to bolster public health departments’ capabilities in managing and responding to tick-borne illnesses.
Key provisions
- Extends the National Strategy for Vector-Borne Diseases.
- Renews funding for regional centers of excellence in vector-borne disease research and prevention.
- Adjusts the funding period for these centers from 2021-2025 to 2026-2030.
- Provides continued support to health departments for addressing vector-borne diseases.
Who is affected
- Public Health Departments
- Researchers in Vector-Borne Diseases
- Individuals at risk of tick-borne diseases
- State and Local Governments
Notable changes
- Extends the authorization period for the Kay Hagan Tick Act.
- Changes the funding timeframe for the National Strategy and regional centers.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
24 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours